Explore

Trendline Trendline
Axsome Therapeutics' Auvelity Approved by FDA for Alzheimer's Agitation, Marking a Significant Advancement

Axsome Therapeutics' Auvelity Approved by FDA for Alzheimer's Agitation, Marking a Significant Advancement

Axsome Therapeutics' Auvelity Approved by FDA for Alzheimer's Agitation, Marking a Significant Advancement
Trendline Trendline
Moderna's Revenue Surges in Q1 Due to Strong International Vaccine Sales

Moderna's Revenue Surges in Q1 Due to Strong International Vaccine Sales

Moderna's Revenue Surges in Q1 Due to Strong International Vaccine Sales
Trendline Trendline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline

Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline

Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline
Trendline Trendline
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Trendline Trendline
Corcept Therapeutics Reports Q1 2026 Financial Results and FDA Approval of New Cancer Treatment

Corcept Therapeutics Reports Q1 2026 Financial Results and FDA Approval of New Cancer Treatment

Corcept Therapeutics Reports Q1 2026 Financial Results and FDA Approval of New Cancer Treatment
Trendline Trendline
Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy
Trendline Trendline
Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion

Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion

Novocure Reports 12% Revenue Growth in Q1 2026 Driven by Global Expansion
Trendline Trendline
FDA Panel Delivers Mixed Verdict on AstraZeneca's Cancer Drugs

FDA Panel Delivers Mixed Verdict on AstraZeneca's Cancer Drugs

FDA Panel Delivers Mixed Verdict on AstraZeneca's Cancer Drugs
Trendline Trendline
Eli Lilly Announces Strong Q1 2026 Financial Results and Raises Full-Year Guidance

Eli Lilly Announces Strong Q1 2026 Financial Results and Raises Full-Year Guidance

Eli Lilly Announces Strong Q1 2026 Financial Results and Raises Full-Year Guidance
Trendline Trendline
Avalyn Pharma Targets $300 Million in Upscaled IPO for Respiratory Therapies

Avalyn Pharma Targets $300 Million in Upscaled IPO for Respiratory Therapies

Avalyn Pharma Targets $300 Million in Upscaled IPO for Respiratory Therapies
Trendline Trendline
Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies

Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies

Bicycle Therapeutics Reports Q1 2026 Financial Results, Highlights Progress in Cancer Therapies
Trendline Trendline
Eli Lilly's Stock Rises Following Strong Q1 Results and Raised Guidance

Eli Lilly's Stock Rises Following Strong Q1 Results and Raised Guidance

Eli Lilly's Stock Rises Following Strong Q1 Results and Raised Guidance